Morana Vojnic

10PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 02, 2026
Utility of cerebrospinal fluid circulating tumor cell quantification and next-generation sequencing in patients with suspicion for leptomeningeal disease.

Amanda Onoichenco, Rosivel Galvez, Aaliyah Schultz

|Mar 18, 2026
Identification of BRAF V600E Mutation in Cerebrospinal Fluid Aids in Diagnosing Leptomeningeal Carcinomatosis Arising From Pleomorphic Xanthoastrocytoma: A Case Report.

Randy S D'Amico, Patricia Avancena, Alon Kashanian

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

|Jan 13, 2025
Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics: A Systematic Review.

Sandra Leskinen, Samir Alsalek, Rosivel Galvez

|Oct 16, 2024
Prioritizing Radiation and Targeted Systemic Therapies in Patients with Resected Brain Metastases from Lung Cancer Primaries with Targetable Mutations: A Report from a Multi-Site Single Institution.

Yen-Ruh Wuu, Mostafa Kokabee, Bin Gui

|Sep 11, 2024
Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification.

Arielle Elkrief, Igor Odintsov, Roger S Smith

Pageof 2

Frequent Collaborators

4 joint publications

Alexander Drilon

3 joint publications

Allan J W Lui

2 joint publications

Eric Gladstone

2 joint publications

Igor Odintsov